Related to Multiplicom Wins $260K to Develop Maternal Blood Test for Fetal Aneuploidies

• Look, No Label! Label-Free MST
  Two articles report on two methods that provided different levels of information on the differentiation of binding sites available on protein targets of interest.
  
• 7 Biotech Trends for the Coming Year
  What does 2013 hold for the industry?
  
• 10 Predictions That Will Transform Healthcare
  Peer into GEN's crystal ball for a glimpse of what's to come.
  
• Literature Review: Mega-Selection
  Researchers present a method that uses combinatorial antibody libraries to endow cells with new binding energy landscapes to regulate their phenotypes.
  
• SBIR Thinks Smaller
  New rules taking effect on January 28 aim to draw investor-owned smaller biopharmas to the federal grant program and STTR, its companion.
  
• Literature Review: ELISA—Detected Through A Quick Glance
  Researchers provide an assay chemistry that allows for a direct visual scoring of an ELISA result to detect protein analytes at ultralow concentrations.
  
• Isothermal PCR Gets Off The Dime
  Two companies aim to make PCR and its need for thermal cycling instrumentation obsolete.
  
• Funding Squeeze Traps Young Researchers
  Postdocs look beyond NIH funding as, despite policy changes, the percentage and age of first-time grant winners stay steady.
  
• Literature Review: Protein—Now You See It, Now You Don't
  Researchers describe a system for the rapid and complete degradation of proteins in mammalian cells.
  
• Literature Review: BioMAP—Antibiotic Fingerprints
  Researchers show that bioactivity fingerprinting can help with profiling antibiotic lead compounds.
  
• 20 Grants for Young Researchers
  Looking for funding? Here are some places to start.
  
• Literature Review: A Flying Drop Becomes a Hanging Drop
  Researchers apply acoustic liquid-transfer technology to protein crystallization.
  
• Literature Review: Bacteria Reprogram Host Cells in Order to Survive and Spread
  Researchers describe how leprosy bacilli can change Schwann cells to stem cell-like cells to promote infection.
  
• Literature Review: Which Drug Combination Will Unlock Triple-Negative Breast Cancer?
  Researchers describe a strategy for treating TNBC that combines noncompetitive antibodies to achieve degradation of EGFR and tumor inhibition.
  
• Detecting Acquired Drug Resistance in Cancer
  New methods allow noninvasive analysis in blood plasma.
  
• Your Genes, Your Choice?
  Critics say the American College of Medical Genetics and Genomics’ recent recommendations for reporting incidental clinical sequencing results undermine patient autonomy.
  
• Literature Review: A Step Closer to Personalized Medicine
  Researchers use patient-specific cell lines derived in mice to personalize chemotherapy.
  
• Moving Genomics Closer to the Clinic
  Foundation Medicine and Memorial Sloan-Kettering Cancer Center are working to translate genomic information into personalized cancer treatment.
  
• GEN Hall of Shame
  Meet the Congressional enemies of research funding.
  
• LAVAgel for Protein Diagnostics
  Researchers introduce a microfluidic, single-channel, multistage immunoblotting strategy toward scalable protein isoform analysis.